Clinical Trials Browser

Phase 2 × Interventional × Human Epidermal Growth Factor 2 Negative Carcinoma of Breast × Clear all

NCT03854617 2019-02-26

A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer

Phase 2 Unknown

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast